G Medical Innovations Holdings Limited Profit Margin

G Medical Innovations Holdings Limited posts a profit margin of -116.04% as of June 2022. That compares with -554.41% in the prior-year period — up 79.1% year over year. That is below the Healthcare sector average of 19.13%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, G Medical Innovations Holdings Limited's profit margin was -554.41%. The latest reading is -116.04% — a 79.1% year-over-year increase (period ending June 2022). Use the history and growth charts on this page for a longer lookback.

For Healthcare stocks, a profit margin near 19.13% is typical. G Medical Innovations Holdings Limited's -116.04% is lower that level. That is roughly 706.5% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

G Medical Innovations Holdings Limited's profit margin moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is -116.04% as of June 2022; use YoY and peer views to separate noise from signal.

Context for GMVD's profit margin usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 19.13%), and (3) consistency with growth and profitability. This page covers the first two; G Medical Innovations Holdings Limited's other metric pages and overview cover the third.